Nektar Therapeutics (NKTR) Raw Materials (2010 - 2024)

Nektar Therapeutics' Raw Materials history runs 13 years deep, the most recent figure standing at $1.7 million for Q2 2024.

• In Q2 2024, Raw Materials changed N/A year-over-year to $1.7 million; the TTM figure through Jun 2024 stood at $1.7 million (changed N/A YoY), while the FY2023 annual figure was $1.9 million, down 27.73% from the prior year.
• Raw Materials was $1.7 million for Q2 2024 at Nektar Therapeutics, down from $1.9 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.6 million in Q4 2022 to a low of $1.7 million in Q2 2024.
• Historically, Raw Materials has averaged $2.0 million across 3 years, with a median of $1.9 million in 2023.
• Biggest YoY gain for Raw Materials was 27.73% in 2023; the steepest drop was 27.73% in 2023.
• A 3-year view of Raw Materials shows it stood at $2.6 million in 2022, then slipped by 27.73% to $1.9 million in 2023, then fell by 7.63% to $1.7 million in 2024.
• The last three Raw Materials figures came in at $1.7 million (Q2 2024), $1.9 million (Q1 2024), and $1.9 million (Q4 2023), per Business Quant data.